Bernd Schlereth

MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

Klaus Brischwein, Bernd Schlereth, Benjamin Guller et al. · Molecular Immunology · 2005 · 257 citations

Medicine, Immunology, Antibody Engineering +6

T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct

Torsten Dreier, Patrick A. Baeuerle, Iduna Fichtner et al. · The Journal of Immunology · 2003 · 194 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Therapeutic Effect +14

Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class

Klaus Brischwein, Larissa Parr, Stefan Pflanz et al. · Journal of Immunotherapy · 2007 · 188 citations

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110

Cornelia Haas, Eva Krinner, Klaus Brischwein et al. · Immunobiology · 2009 · 179 citations

Cytotoxic Action, Autoimmune Disease, Immunology +9

Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct

Bernd Schlereth, Iduna Fichtner, Grit Lorenczewski et al. · Cancer Research · 2005 · 127 citations

Bispecific T-cell Engager, Immunology, Ovarian Cancer Metastases +18